# US 2024/0189009 A1 · Cryosurgical device and materials and method of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189009 A1
- Document ID: US20240189009A1
- Status: Published application
- Kind: A1
- Application number: 18/419,796
- Filed: 2024-01-23
- Published: 2024-06-13
- Earliest claimed: 2022-02-07
- Inventors: Martin J. MOSKOVITZ
- Web page: https://patentgrep.com/patent/US20240189009A1

## CPC

- A61B 18/0218: {with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip}
- A61F 7/0085: {Devices for generating hot or cold treatment fluids}
- A61F 7/12: Devices for heating or cooling internal body cavities
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61B 2018/00464: {Subcutaneous fat, e.g. liposuction, lipolysis}
- A61B 2018/00672: {lower}
- A61B 2018/00678: {upper}
- A61B 2018/00714: {Temperature}
- A61B 2018/00744: {Fluid flow}
- A61B 2018/0293: {using an instrument interstitially inserted into the body, e.g. needle}
- A61F 2007/0059: {with an open fluid circuit}
- A61F 2007/0063: {for cooling}
- A61F 2007/029: {Fat cell removal or destruction by non-ablative heat treatment}
- A61F 2007/126: {for invasive application, e.g. for introducing into blood vessels}
- A61M 5/1408: {in parallel, e.g. by manifolds or with sequencing valves}
- A61M 5/142: Pressure infusion, e.g. using pumps
- A61M 5/14232: {Roller pumps}
- A61M 5/44: having means for cooling or heating the devices or media
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Provided in the present disclosure are materials, devices, systems, and methods for performing cryo-surgery in a mammalian subject. More particularly, presented are a slurry, devices, systems, and methods for subcutaneously injecting the slurry into a patient in need of bodyfat reduction intervention. The slurry, devices, systems, and methods permit highly efficacious subcutaneous ice phase-change lipolysis while not requiring that the patient be placed under general anesthesia, nor requiring significant new surgical training among practitioners.

## Claims

### Claim 1

An aqueous solution comprising a dissolved monosaccharide and a dissolved salt, the dissolved monosaccharide and salt being of sufficient concentration such that the aqueous solution becomes a slurry of chilled aqueous solution and ice when cooled to a temperature of or below about −1.5° C. while remaining a substantially free-flowing liquid solution mixture.

### Claim 2 (depends on 1)

The aqueous solution of claim 1, wherein the dissolved monosaccharide and salt are of sufficient concentration such that the aqueous solution becomes a slurry when cooled to a temperature of or below about −1.7° C. while remaining a substantially free-flowing liquid solution mixture.

### Claim 3 (depends on 1)

The aqueous solution of claim 1, wherein the concentration of the monosaccharide is no less than about 12.2 wt %, and the concentration of the salt is no greater than about 0.18 wt %.

### Claim 4 (depends on 1)

The aqueous solution of claim 1 wherein the monosaccharide has between 3 and 7 carbon atoms.

### Claim 5 (depends on 4)

The aqueous solution of claim 4 wherein the monosaccharide has 6 carbon atoms.

### Claim 6 (depends on 5)

The aqueous solution of claim 5 wherein the monosaccharide is dextrose.

### Claim 7 (depends on 1)

The aqueous solution of claim 1 wherein the salt is a biocompatible salt.

### Claim 8 (depends on 8)

The aqueous solution of claim 8 wherein the salt is sodium chloride.

### Claim 9 (depends on 1)

The aqueous solution of claim 1 wherein the monosaccharide is dextrose, and the salt is sodium chloride.

### Claim 10

A surgical injection device comprising:
a container configured to contain a slurry therewithin; and
a surgical pump operably coupled to the container to facilitate administering the slurry from the container to a patient via a patient tube,
wherein the container comprises a mixing means configured to agitate the slurry so as to maintain a predetermined liquid-ice ratio and/or consistency.

### Claim 11 (depends on 10)

The surgical injection device of claim 10 wherein the mixing means comprises one or more mixing tubes each attached to the container at both ends, and a mixing pump associated with each of the tubes and configured to circulate slurry from the container through the mixing tubes, thereby providing the agitation.

### Claim 12 (depends on 11)

The surgical injection device of claim 11, comprising two or more mixing tubes and two or more mixing pumps, each associated with one of the tubes.

### Claim 13 (depends on 11)

The surgical injection device of claim 11, wherein each of the mixing pumps comprises a peristaltic pump.

### Claim 14 (depends on 11)

The surgical injection device of claim 11, the container having a downwardly tapering shape, wherein one end of each of the mixing tubes is attached to the container at a lower end thereof.

### Claim 15 (depends on 10)

The surgical injection device of claim 10, wherein the mixing means comprises an augur internal to the container.

### Claim 16 (depends on 10)

The surgical injection device of claim 10 wherein the surgical pump comprises a peristatic roller pump.

### Claim 17 (depends on 10)

The surgical injection device of claim 10 further comprising an instillation needle operably coupled to the surgical pump via the patient tube.

### Claim 18 (depends on 10)

The surgical injection device of claim 10 further comprising a lid for closing the container.

### Claim 19 (depends on 10)

The surgical injection device of claim 10, the slurry being a mixture of chilled aqueous solution and ice, wherein the aqueous solution comprises a dissolved monosaccharide and a dissolved salt.

### Claim 20 (depends on 19)

The surgical injection device of claim 19, the dissolved monosaccharide and salt being of sufficient concentration such that the aqueous solution becomes a slurry when cooled to a temperature of or below −1.5° C. while remaining a substantially free-flowing liquid solution mixture.

### Claim 21 (depends on 20)

The surgical injection device of claim 20 wherein the monosaccharide is dextrose and the salt is sodium chloride.

### Claim 22 (depends on 10)

The surgical injection device of claim 10 being configured to administer the slurry at a sufficiently cold temperature suitable for ice phase-change lipolysis when in contact with live mammalian fat cells.

### Claim 23 (depends on 10)

The surgical injection device of claim 10 wherein the container is substantially surrounded by a cooling element, the cooling element being configured to maintain the contents of the container at an operating temperature.

### Claim 24 (depends on 10)

The surgical injection device of claim 10 further comprising a refrigerated hold chamber configured to receive therewithin one or more containers comprising aqueous solution and/or slurry, and to maintain them at a predefined cold temperature.

### Claim 25 (depends on 1)

A method of causing ice phase-change lipolysis in a mammalian subject, the method comprising subcutaneously injecting a slurry of chilled aqueous solution and ice such that the slurry comes into proximity with fat cells to be ice-phase-lipolysed, the slurry being made by cooling the aqueous solution of claim 1 to a temperature no greater than about −1.5° C.

### Claim 26 (depends on 25)

The method of claim 25, the dissolved monosaccharide and salt being of sufficient concentration such that the aqueous solution becomes the slurry when cooled to a temperature of or below about −1.5° C. while remaining a substantially free-flowing liquid solution mixture.

### Claim 27 (depends on 25)

The method of claim 25 wherein the monosaccharide is dextrose and the salt is sodium chloride.

### Claim 28 (depends on 5, 10)

The method of claim 5 wherein the injection is performed using the surgical injection device of claim 10.

### Claim 29 (depends on 25)

The method of claim 25, wherein the slurry is injected at a temperature between about −0.5° C. and about −1.7° C.
